Literature DB >> 20363761

Primary sources and immunological prerequisites for sST2 secretion in humans.

Michael Mildner1, Angela Storka, Michael Lichtenauer, Veronika Mlitz, Minoo Ghannadan, Konrad Hoetzenecker, Stefanie Nickl, Balazs Dome, Erwin Tschachler, Hendrik Jan Ankersmit.   

Abstract

AIMS: Serum levels of the soluble growth stimulation gene-2 (sST2) are elevated in heart and pulmonary diseases. However, the relationship of the sST2/interleukin (IL)-33 axis and its triggers as well as its organ distribution is still not known. This study was thus designed to investigate the cellular origin and regulation of sST2 and IL-33 in vitro and in vivo. METHODS AND
RESULTS: sST2 and IL-33 gene expression and protein secretion were analysed in pooled organ-specific cDNAs and in primary cell cultures, respectively, by RT-PCR and ELISA technology. The strongest sST2 mRNA expression was detected in heart and lung tissues, which correlated with spontaneous secretion of sST2 protein in vitro. The inflammatory cytokines IL-1alpha, IL-1beta, and tumour necrosis factor alpha as well as supernatants of lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells led to an enhanced secretion of sST2 in cultured cardiac myocytes and lung alveolar epithelial cells. These cytokines enhanced sST2 secretion via an NFkappaB-dependent mechanism. In addition, LPS stimulation in humans in vivo induced a short-term inflammatory response that was followed by a massive enhancement of sST2 secretion.
CONCLUSION: These results identify the primary sources and inflammatory triggers for the enhancement of sST2 secretion and demonstrate a relationship between inflammation and the secretion of a bioactive member of the IL-1R family, both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363761     DOI: 10.1093/cvr/cvq104

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  52 in total

1.  Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.

Authors:  Jennifer E Ho; Wei-Yu Chen; Ming-Huei Chen; Martin G Larson; Elizabeth L McCabe; Susan Cheng; Anahita Ghorbani; Erin Coglianese; Valur Emilsson; Andrew D Johnson; Stefan Walter; Nora Franceschini; Christopher J O'Donnell; Abbas Dehghan; Chen Lu; Daniel Levy; Christopher Newton-Cheh; Honghuang Lin; Janine F Felix; Eric R Schreiter; Ramachandran S Vasan; James L Januzzi; Richard T Lee; Thomas J Wang
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Dynamic role of epithelium-derived cytokines in asthma.

Authors:  Kathleen R Bartemes; Hirohito Kita
Journal:  Clin Immunol       Date:  2012-03-20       Impact factor: 3.969

Review 3.  Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world.

Authors:  Dike Ojji; Elena Libhaber; Kim Lamont; Friedrich Thienemann; Karen Sliwa
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

4.  Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.

Authors:  Hemanth Ramaprakash; Takehiko Shibata; Karen E Duffy; Ugur B Ismailoglu; Rachel M Bredernitz; Ana Paula Moreira; Ana L Coelho; Anuk M Das; Natalie Fursov; Geoffrey L Chupp; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

5.  Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33.

Authors:  Wei-Yu Chen; Jaewoo Hong; Joseph Gannon; Rahul Kakkar; Richard T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

Review 6.  Interleukin-33 in health and disease.

Authors:  Foo Yew Liew; Jean-Philippe Girard; Heth Roderick Turnquist
Journal:  Nat Rev Immunol       Date:  2016-09-19       Impact factor: 53.106

7.  Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery.

Authors:  Dipal M Patel; Heather Thiessen-Philbrook; Jeremiah R Brown; Eric McArthur; Dennis G Moledina; Sherry G Mansour; Michael G Shlipak; Jay L Koyner; Peter Kavsak; Richard P Whitlock; Allen D Everett; David J Malenka; Amit X Garg; Steven G Coca; Chirag R Parikh
Journal:  Am Heart J       Date:  2019-12-03       Impact factor: 4.749

Review 8.  IL-33 in obesity: where do we go from here?

Authors:  Marcos Felipe Andrade de Oliveira; André Talvani; Etel Rocha-Vieira
Journal:  Inflamm Res       Date:  2019-01-17       Impact factor: 4.575

9.  Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune response.

Authors:  Tamara Stampalija; Roberto Romero; Steven J Korzeniewski; Piya Chaemsaithong; Jezid Miranda; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-06-25

10.  Soluble ST2, a modulator of the inflammatory response, in preterm and term labor.

Authors:  Tamara Stampalija; Tinnakorn Chaiworapongsa; Roberto Romero; Adi L Tarca; Gaurav Bhatti; Po Jen Chiang; Nandor Gabor Than; Enrico Ferrazzi; Sonia S Hassan; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.